Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant ERK1 anticorps (pThr185, pThr202)

Cet anticorps anti-ERK1 est un anticorps Lapin Monoclonal détectant ERK1 dans WB, IHC, ELISA et IF. Adapté pour Humain.
N° du produit ABIN7127707

Aperçu rapide pour Recombinant ERK1 anticorps (pThr185, pThr202) (ABIN7127707)

Antigène

Voir toutes ERK1 (MAPK3) Anticorps
ERK1 (MAPK3) (Mitogen-Activated Protein Kinase 3 (MAPK3))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 224
  • 164
  • 136
  • 44
  • 20
  • 19
  • 16
  • 12
  • 10
  • 9
  • 9
  • 7
  • 7
  • 7
  • 5
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 231
  • 31
  • 3
  • 1
  • 1
Lapin

Clonalité

  • 201
  • 66
Monoclonal

Conjugué

  • 124
  • 16
  • 16
  • 13
  • 7
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Cet anticorp ERK1 est non-conjugé

Application

  • 216
  • 83
  • 82
  • 65
  • 65
  • 47
  • 47
  • 39
  • 32
  • 30
  • 18
  • 11
  • 7
  • 5
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)

Clone

2D5
  • Épitope

    • 71
    • 50
    • 25
    • 16
    • 15
    • 15
    • 14
    • 11
    • 11
    • 9
    • 8
    • 7
    • 6
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pThr185, pThr202

    Fonction

    Phospho-MAPK3 (T202) + MAPK1 (T185) Recombinant Monoclonal Antibody

    Purification

    Affinity-chromatography

    Immunogène

    A synthesized peptide derived from human Phospho-MAPK3 (T202) + MAPK1 (T185)

    Isotype

    IgG
  • Indications d'application

    WB:1:500-1:5000, IHC:1:50-1:200, IF:1:20-1:200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    ERK1 (MAPK3) (Mitogen-Activated Protein Kinase 3 (MAPK3))

    Autre désignation

    MAPK3

    Sujet

    Background: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade plays also a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade.

    Aliases: Mitogen-activated protein kinase 3, MAP kinase 3, MAPK 3, ERT2, Extracellular signal-regulated kinase 1, ERK-1, Insulin-stimulated MAP2 kinase, MAP kinase isoform p44, p44-MAPK, Microtubule-associated protein 2 kinase, p44-ERK1, MAPK3, ERK1, PRKM3

    UniProt

    P27361

    Pathways

    Signalisation MAPK, Signalisation RTK, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway, Response to Growth Hormone Stimulus, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGFR1 Specific Signals, S100 Proteins
Vous êtes ici:
Chat with us!